Bridgeway Capital Management’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-146,502
Closed -$2.56M 1269
2024
Q4
$2.56M Sell
146,502
-1,356,517
-90% -$18.3M 0.06% 449
2024
Q3
$17.3M Buy
1,503,019
+159,435
+12% +$1.83M 0.37% 61
2024
Q2
$15.2M Buy
1,343,584
+45,360
+3% +$604K 0.36% 68
2024
Q1
$18.6M Buy
1,298,224
+44,374
+4% +$629K 0.38% 36
2023
Q4
$17.2M Buy
1,253,850
+133,619
+12% +$1.41M 0.37% 38
2023
Q3
$9.11M Buy
1,120,231
+56,852
+5% +$465K 0.22% 127
2023
Q2
$8.05M Buy
1,063,379
+965,684
+988% +$7.37M 0.19% 156
2023
Q1
$782K Buy
97,695
+23,195
+31% +$239K 0.02% 782
2022
Q4
$846K Hold
74,500
0.02% 772
2022
Q3
$650K Buy
74,500
+54,500
+273% +$566K 0.02% 831
2022
Q2
$199K Buy
+20,000
New +$201K ﹤0.01% 1091

Other funds holding PTVE

Bridgeway Capital Management's PTVE Position: Q1 2025 in Review

Bridgeway Capital Management sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q1 2025, closing a stake of 146,502 shares — an estimated $2.56M sold.

Bridgeway Capital Management first reported a position in PTVE in Q2 2022 and held it in 11 quarters. The position peaked at $18.6M in Q1 2024. 163 funds tracked by Wall St. Rank hold PTVE as of Q1 2025.

  • Bridgeway Capital Management reported no remaining Pactiv Evergreen Inc. Common stock position as of Q1 2025 after selling out during the quarter.
  • Bridgeway Capital Management sold 146,502 Pactiv Evergreen Inc. Common stock shares in Q1 2025, an estimated $2.56M.
  • Bridgeway Capital Management first reported a position in Pactiv Evergreen Inc. Common stock in Q2 2022 and held it in 11 quarters.
  • Bridgeway Capital Management's Pactiv Evergreen Inc. Common stock position peaked at $18.6M in Q1 2024.
  • 163 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q1 2025.

Based on Bridgeway Capital Management's 13F filing for Q1 2025, filed 15 May 2025.